GlassScriptPhysician profile
Nancy L Schwartzman
NPI 1952335218
$1,400.58
in general payments reported to CMS, 2019-2025
19 companies · $240 in 2025
The $240 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $292 · 2021: $352 · 2022: $149 · 2024: $158 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $211.27 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Ironshore Pharmaceuticals INC. | $178.01 | 2019-2024 | |
| Kaleo, INC. | $172.52 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.26 | 2020-2021 | |
| Cranial Technologies, INC | $126.36 | 2020-2025 | Doc Band |
| Pfizer INC. | $90.91 | 2024-2025 | |
| Sanofi Pasteur INC. | $71.88 | 2020-2025 | |
| Sobi, INC | $56.19 | 2019-2022 | |
| Covis Pharma Gmbh | $55.55 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $51.16 | 2025 | Neffy |
| Seqirus USA INC | $50.38 | 2021-2024 | Flucelvax |
| Abbvie INC. | $42.69 | 2020-2021 | |
| Genentech USA, INC. | $41.70 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $33.84 | 2025 | Zoryve |
| Collegium Pharmaceutical, INC. | $22.07 | 2025 | Jornay Pm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.29 | 2021 | |
| Phadia US INC. | $18.89 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.49 | 2019 | |
| Bavarian Nordic A/S | $14.12 | 2025 | Vivotif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Schwartzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.